Table 2 Functional assessments at entry (n=50)

From: XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer

Functional assessment

Patients (%)

Activity of daily living index

 No dependence

58

 Light dependency

24

 Moderate dependency

14

 Serious dependency

4

Instrumental activity of daily living index

 Autonomous

58

 Light dependency

30

 Moderate dependency

8

 Serious dependency

4

Charlson comorbidity scale

 0

60

 1

26

 2

8

 3

6

Back to article page